Investigator and independent review committee exploratory assessment and verification of tumor response in a non-Hodgkin lymphoma study

Authors

Robert R Ford, Clinical Trials Imaging Consulting LLC
Robert W Ford, Thomas Jefferson University Hospital
Michael O'Neal, BioClinica Inc
Brad S Kahl, Washington University School of Medicine in St. Louis
Ling Chen, Teva Branded Pharmaceutical Products R&D Inc
Mihaela Munteanu, Teva Branded Pharmaceutical Products R&D Inc
Bruce D Cheson, Georgetown University

Journal

Leukemia & Lymphoma

Publication Date

6-1-2017

Volume

58

Issue

6

First Page

1332

Last Page

1340

Document Type

Open Access Publication

DOI

10.1080/10428194.2016.1233535

Rights and Permissions

Ford RR, Ford RW, O'Neal M, Kahl BS, Chen L, Munteanu M, Cheson BD. Investigator and independent review committee exploratory assessment and verification of tumor response in a non-Hodgkin lymphoma study. Leuk Lymphoma. 2017 Jun;58(6):1332-1340. doi.org/10.1080/10428194.2016.1233535 Copyright 2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.

Recommended Citation

Ford, Robert R; Ford, Robert W; O'Neal, Michael; Kahl, Brad S; Chen, Ling; Munteanu, Mihaela; and Cheson, Bruce D, "Investigator and independent review committee exploratory assessment and verification of tumor response in a non-Hodgkin lymphoma study." Leukemia & Lymphoma. 58, 6. 1332 - 1340. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/11618